Aeolian Biotech Corp
October 18, 2023
Franciscan C
Infectious Diseases
Aeolian Biotech Corp is committed to creating an improved, next generation pneumococcal conjugate vaccine (iPCV22) that is designed to provide best in class coverage for adults.
Speakers
Company Type
Privately Funded
Website
http://www.aeolianbiotech.com
CEO/Top Company Official
Tyler Martin, MD
Lead Product in Development
Pneumococcal Conjugate Vaccine
Number Of Unlicensed Products
1
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)